Chu Yu-Waye 4
4 · CytomX Therapeutics, Inc. · Filed Jul 20, 2023
Insider Transaction Report
Form 4
Chu Yu-Waye
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-07-19+375,000→ 375,000 totalExercise: $1.82Exp: 2033-07-18→ Common Stock (375,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the one year anniversary measured from July 19, 2023 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.